163 related articles for article (PubMed ID: 26235452)
1. Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.
Shah AC; Minturn JE; Li Y; Belasco JB; Phillips PC; Kang TI; Cole KA; Waanders AJ; Pollack R; Didomenico C; Wildes C; Fisher MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):21-6. PubMed ID: 26235452
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Dodgshun AJ; Hansford JR; Cole T; Choo S; Sullivan MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):17-20. PubMed ID: 26207610
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma: How Far Should we Push?
Lafay-Cousin L
Pediatr Blood Cancer; 2016 Jan; 63(1):9-10. PubMed ID: 26451866
[No Abstract] [Full Text] [Related]
5. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.
Lafay-Cousin L; Holm S; Qaddoumi I; Nicolin G; Bartels U; Tabori U; Huang A; Bouffet E
Cancer; 2005 Jun; 103(12):2636-42. PubMed ID: 15861409
[TBL] [Abstract][Full Text] [Related]
6. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
Broome CB; Schiff RI; Friedman HS
Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma.
Genc DB; Canpolat C; Berrak SG
Support Care Cancer; 2012 Feb; 20(2):385-93. PubMed ID: 21416159
[TBL] [Abstract][Full Text] [Related]
8. Immediate type hypersensitivity to chemotherapeutic agents in pediatric patients.
Visitsunthorn N; Utsawapreechawong W; Pacharn P; Jirapongsananuruk O; Vichyanond P
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):191-7. PubMed ID: 20232573
[TBL] [Abstract][Full Text] [Related]
9. Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low-Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Genc DB; Berrak SG; Canpolat C
Pediatr Blood Cancer; 2016 Jan; 63(1):174. PubMed ID: 26313156
[No Abstract] [Full Text] [Related]
10. Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Dodgshun AJ; Hansford JR; Cole T; Choo S; Sullivan MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):175. PubMed ID: 26398340
[No Abstract] [Full Text] [Related]
11. Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions.
Ruggiero A; Rizzo D; Catalano M; Maurizi P; Mastrangelo S; Attinà G; Riccardi R
Front Pharmacol; 2017; 8():179. PubMed ID: 28439238
[No Abstract] [Full Text] [Related]
12. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
13. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
14. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin hypersensitivity and desensitization in an infant.
Montiel Herrera JM; Góngora-Melendez MA; Pineda-Maldonado ML; Medina-Sanson A; Del Rio Chivardi JM; Del Río-Navarro BE; Rosas-Vargas MA
Ther Drug Monit; 2010 Aug; 32(4):525-8. PubMed ID: 20463633
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with carboplatin desensitization: A case series in a paediatric hospital.
Rodríguez Del Río P; Andión M; Ruano D; Escudero C; Méndez Brea P; Sánchez-García S; Ibáñez MD
Pediatr Allergy Immunol; 2018 Feb; 29(1):111-115. PubMed ID: 28981992
[No Abstract] [Full Text] [Related]
17. Outpatient carboplatin desensitization in a pediatric patient with bilateral optic glioma.
Sims-McCallum RP
Ann Pharmacother; 2000 Apr; 34(4):477-8. PubMed ID: 10772434
[TBL] [Abstract][Full Text] [Related]
18. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
Wu HL
J Oncol Pharm Pract; 2019 Sep; 25(6):1388-1395. PubMed ID: 30176784
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin hypersensitivity reactions: a single institution experience.
Zorzou MP; Efstathiou E; Galani E; Bozas G; Kastritis E; Papadimitriou C; Dimopoulos MA; Bamias A
J Chemother; 2005 Feb; 17(1):104-10. PubMed ID: 15828452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
